Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-16-108384

Options or other derivatives

  • Director acquired 89,773 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BRACA JOHN N · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-06-13 Grant or award : show line 1 in the form Company Stock Option +89,773 $0.11 $9,875 89,773 D
Loading xslF345X03/v442330_4.xml…